NemaLife
NemaLife is a TechBio company that combines C. elegans nematodes, microfluidic organism-on-chip devices and AI-driven imaging to run fast in vivo safety and efficacy screening of bioactive ingredients. It sells preclinical screening services and multi-ingredient formulation work to ingredient suppliers, consumer brands and pharma/biotech clients. It is also starting internal discovery programs to create bioactive assets it can commercialize. The company is privately held and funded largely by NIH grants (NCCIH, NIDA, NIA), including a $300K NCCIH grant in 2024, plus an investment from Motif FoodWorks. Reported total funding is about $0.6M–$2.3M, depending on the source.
Funding
Every round, secondary, debt facility or acquisition involving NemaLife that AI Lounge tracks, newest first.
No rounds recorded yet.
Members see every AI company on AI Lounge with revenue, funding, valuation and investors, searchable and sortable, free.
Create my free account →Log in